Immix Biopharma Inc’s recently made public that its CEO and Chairman Rachman Ilya M acquired Company’s shares for reported $4999.0 on Jun 18 ’25. In the deal valued at $2.29 per share,2,178 shares were bought. As a result of this transaction, Rachman Ilya M now holds 1,138,437 shares worth roughly $3.14 million.
Then, Morris Gabriel S bought 2,225 shares, generating $5,071 in total proceeds. Upon buying the shares at $2.28, the CFO now owns 288,059 shares.
Before that, Hsu Jason bought 40,000 shares. Immix Biopharma Inc shares valued at $87,680 were divested by the Director at a price of $2.19 per share. As a result of the transaction, Hsu Jason now holds 893,000 shares, worth roughly $2.46 million.
Price Performance Review of IMMX
On Tuesday, Immix Biopharma Inc [NASDAQ:IMMX] saw its stock fall -4.50% to $2.76. Over the last five days, the stock has gained 3.76%. Immix Biopharma Inc shares have risen nearly 37.31% since the year began. Nevertheless, the stocks have risen 25.45% over the past one year. While a 52-week high of $3.00 was reached on 07/15/25, a 52-week low of $1.26 was recorded on 04/08/25.
Levels Of Support And Resistance For IMMX Stock
The 24-hour chart illustrates a support level at 2.63, which if violated will result in even more drops to 2.50. On the upside, there is a resistance level at 2.99. A further resistance level may holdings at 3.22.
How much short interest is there in Immix Biopharma Inc?
A steep rise in short interest was recorded in Immix Biopharma Inc stocks on 2025-06-13, growing by 33034.0 shares to a total of 0.25 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.21 million shares. There was a rise of 13.4%, which implies that there is a positive sentiment for the stock.
